Promotional Materials
Manage digital assets as part of your enterprise platform
With full support for image and video formats, you can collaboratively review materials, share with colleagues and publish all within the CARA Life Sciences Platform. With our preview panel, and the seamlessly integrated annotation and review tools, storing, processing, and tracking content in one system is simple.
Leveraging our functionality to perform image recognition and automatically tag images with metadata, as well as using thumbnails, in-line video, image preview, and video annotations, the entire lifecycle of digital assets can be managed effectively and securely, including traceability of where assets are used in case they need to be modified or recalled.
Bringing the best innovations outside of Life Sciences
Benefits
Digital Assets
Functionality for thumbnails, previews, and annotation of images and assets, including automatic tagging.
Content Import & Creation
Create or import content (including in bulk) from templates, assigning required metadata.
Compliance
Re-use materials, including publishing to submissions where required for particular markets.
Re-use
Review (including real-time collaboration) and approval of content via workflows with eSignatures. Compare documents and images across versions.
Benefits
Digital Assets
Content Import & Creation
Functionality for thumbnails, previews, and annotation of images and assets, including automatic tagging.
Create or import content (including in bulk) from templates, assigning required metadata.
Compliance
Re-use
Re-use materials, including publishing to submissions where required for particular markets.
Review (including real-time collaboration) and approval of content via workflows with eSignatures. Compare documents and images across versions.
Latest Resources
Replacing Legacy Systems at Scale: Bayer’s Global Migration to the CARA Platform
85,000 Users 900,000 Documents Documentum Replacement A global upgrade involving almost million regulatory documents, streamlined infrastructure, and a strategic move from Documentum to the
Generis Celebrates New Milestone: Egyptian Drug Authority Chooses EXTEDOpulse Powered by CARA
We are proud to congratulate our partner EXTEDO on the signing of a new agreement with Digital Access to Finance (DAF), under the witness of
Bridging the Gap: AI for Life Sciences Without Compromising Compliance
Generic AI tools can’t handle pharma’s reality. They don’t guarantee audit trails. They fragment your validated systems. They create regulatory risks faster than they solve
